Drug intelligence / Profile preview

Glucerna REX

Development stage
Unknown
Lead developer
Otsuka Pharmaceutical Factory, Inc.
Modality
Peptides, Small Molecules
Administration
Oral, Enteral
01

Overview

Glucerna REX is a specialized liquid enteral nutritional formula designed for the dietary management of individuals with diabetes mellitus or stress-induced hyperglycemia. Developed and marketed in Japan by Otsuka Pharmaceutical Factory in collaboration with Abbott, it is formulated with a unique slow-release carbohydrate blend that has a low glycemic index to help minimize postprandial blood glucose fluctuations. The product is high in monounsaturated fatty acids (MUFA) and contains dietary fiber and fructooligosaccharides to support gastrointestinal health and improve insulin sensitivity. It is primarily utilized in clinical settings for patients requiring tube feeding or as an oral nutritional supplement to provide balanced nutrition while maintaining stable glycemic control.

Brand names
Glucerna REX

Beyond the preview

Go deeper on Glucerna REX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucerna REX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call